Bayer Korea punished for exaggerated ads

Published: 2010-09-17 06:56:00

Updated: 2010-09-17 06:56:00

The Korea Food and Drug Administration has recently reproved Bayer Korea for advertising its vitamin product Redoxon chewable tablet from December last year to April this year, although the company was ordered not to advertise the product due to false or exaggerated ads last year.

The authorit...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK